Lazaros Andronis Selected Research

Strontium-89

1/2017	Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer: results from the TRAPEZE trial (ISRCTN 12808747).
4/2016	Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both: The TRAPEZE Randomized Clinical Trial.
1/2016	TRAPEZE: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of chemotherapy with zoledronic acid, strontium-89, or both, in men with bony metastatic castration-refractory prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lazaros Andronis Research Topics

Disease

3	Prostatic Neoplasms (Prostate Cancer) 01/2017 - 01/2016
2	Neoplasms (Cancer) 04/2019 - 01/2018
2	Pain (Aches) 01/2016 - 01/2016
1	Heart Failure 01/2023
1	Chronic Limb-Threatening Ischemia 01/2022
1	Stillbirth 11/2020
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2020
1	Vitamin D Deficiency 01/2020
1	Rare Diseases (Rare Disease) 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2019
1	Ventilator-Associated Pneumonia 05/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Anuria 04/2017
1	Diabetic Neuropathies (Diabetic Neuropathy) 01/2016

Drug/Important Bio-Agent (IBA)

3	Zoledronic Acid (Zometa)FDA Link 01/2017 - 01/2016
3	Strontium-89IBA 01/2017 - 01/2016
2	Docetaxel (Taxotere)FDA Link 01/2017 - 04/2016
1	Biomarkers (Surrogate Marker)IBA 11/2020
1	nusinersenIBA 01/2020
1	MicronutrientsIBA 01/2020
1	Anaplastic Lymphoma KinaseIBA 04/2019
1	ErbB Receptors (EGF Receptor)IBA 04/2019
1	Denosumab FDA Link 01/2018
1	Diphosphonates (Bisphosphonates)IBA 01/2018
1	Cytidine Monophosphate (CMP)IBA 01/2016

Therapy/Procedure

4	Therapeutics 01/2023 - 01/2016
3	Drug Therapy (Chemotherapy) 04/2019 - 01/2016
1	Surgical Amputation (Amputations) 01/2022
1	Length of Stay 05/2018
1	Critical Care (Surgical Intensive Care) 05/2018
1	Transplantation 04/2017
1	Castration 01/2016
1	Spinal Cord Stimulation 01/2016